Industry: Drug Manufacturers - Specialty & Generic
CEO:Mr. Wenbin Xiao
Full-time employees:4013
City:Nanchang
Address:No. 788 Torch Street
IPO:1996-09-23
CIK:
Website:
General Outlook
When we look at how much money they make before expenses, they keep 0.650% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.219%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.171%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust 0.112% return, is a testament to Jiang Zhong Pharmaceutical Co.,Ltd's adeptness in optimizing resource deployment. Jiang Zhong Pharmaceutical Co.,Ltd's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.184%. Furthermore, the proficiency of Jiang Zhong Pharmaceutical Co.,Ltd in capital utilization is underscored by a remarkable 0.192% return on capital employed.
Stock Prices
Jiang Zhong Pharmaceutical Co.,Ltd's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $24.75, while its low point bottomed out at $24.22. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Jiang Zhong Pharmaceutical Co.,Ltd's stock market.
Liquidity Ratios
Analyzing 600750.SS liquidity ratios reveals its financial health of the firm.
The current ratio of 168.32% gauges short-term asset coverage for liabilities.
The quick ratio (146.34%) assesses immediate liquidity, while the cash ratio (80.70%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
168.32%
Quick Ratio
146.34%
Cash Ratio
80.70%
Profitability Ratios
600750.SS profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 21.76% underscores its earnings before tax deductions.
The effective tax rate stands at 14.52%, revealing its tax efficiency.
The net income per EBT, 78.74%, and the EBT per EBIT, 99.47%, provide insights into its earnings hierarchy.
Lastly, with an EBIT per revenue ratio of 21.88%, we grasp its operational profitability.
cards.indicator
cards.value
Pretax Profit Margin
21.76%
Effective Tax Rate
14.52%
Net Income per EBT
78.74%
EBT per EBIT
99.47%
EBIT per Revenue
21.88%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 1.68, it details the span from stock purchase to revenue.
The 1 days it takes to settle debts showcases its creditor relations.
Meanwhile, a 1 cash conversion cycle and 434.30% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.
cards.indicator
cards.value
Days of Sales Outstanding
146
Days of Inventory Outstanding
87
Operating Cycle
171.03
Days of Payables Outstanding
41
Cash Conversion Cycle
130
Receivables Turnover
4.34
Payables Turnover
8.93
Inventory Turnover
4.20
Fixed Asset Turnover
2.68
Asset Turnover
0.66
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 1.76, and free cash flow per share, 1.43, depict cash generation on a per-share basis.
The cash per share value, 2.32, showcases liquidity position.
A payout ratio of 0.53 highlights the portion of earnings distributed as dividends.
Lastly, the operating cash flow sales ratio, 0.26, offers insight into cash flow relative to sales.
cards.indicator
cards.value
Operating Cash Flow per Share
1.76
Free Cash Flow per Share
1.43
Cash per Share
2.32
Payout Ratio
0.53
Operating Cash Flow Sales Ratio
0.26
Free Cash Flow to Operating Cash Flow Ratio
0.81
Cash Flow Coverage Ratio
583.89
Short Term Coverage Ratio
1120.64
Capital Expenditure Coverage Ratio
5.31
Dividend Paid and Capex Coverage Ratio
1.83
Dividend Payout Ratio
0.06
Debt and Leverage Ratios
Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 0.03%, highlights its total liabilities relative to assets.
The long-term debt to capitalization, 0.02%, and total debt to capitalization, 0.05%, ratios shed light on its capital structure.
An interest coverage of 174.40 indicates its ability to manage interest expenses.
cards.indicator
cards.value
Debt Ratio
0.03%
Long Term Debt to Capitalization
0.02%
Total Debt to Capitalization
0.05%
Interest Coverage
174.40
Cash Flow to Debt Ratio
583.89
Company Equity Multiplier
1.59
Per Share Data
Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 6.92, provides a glimpse into top-line earnings distributed across each share.
Net income per share, 1.13, reflects the portion of profit attributed to each share.
The book value per share, 6.13, represents the net asset value distributed per share, while the tangible book value per share, 6.53, excludes intangible assets.
cards.indicator
cards.value
Revenue Per Share
6.92
Net Income Per Share
1.13
Book Value Per Share
6.13
Tangible Book Value Per Share
6.53
Shareholders Equity Per Share
6.13
Interest Debt Per Share
0.10
Capex Per Share
-0.33
Growth Ratios
Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 13.53%, indicates top-line expansion, while the gross profit growth, 11.17%, reveals profitability trends.
EBIT growth, 10.23%, and operating income growth, 10.23%, offer insights into operational profitability progression.
The net income growth, 18.40%, showcases bottom-line expansion, and the EPS growth, 17.71%, measures the growth in earnings per share.
cards.indicator
cards.value
Revenue Growth
13.53%
Gross Profit Growth
11.17%
EBIT Growth
10.23%
Operating Income Growth
10.23%
Net Income Growth
18.40%
EPS Growth
17.71%
EPS Diluted Growth
17.71%
Weighted Average Shares Growth
0.27%
Weighted Average Shares Diluted Growth
0.27%
Dividends per Share Growth
8.90%
Operating Cash Flow Growth
6.09%
Free Cash Flow Growth
29.63%
10-Year Revenue Growth per Share
63.83%
5-Year Revenue Growth per Share
147.17%
3-Year Revenue Growth per Share
78.55%
10-Year Operating CF Growth per Share
912.76%
5-Year Operating CF Growth per Share
122.22%
3-Year Operating CF Growth per Share
44.28%
10-Year Net Income Growth per Share
332.42%
5-Year Net Income Growth per Share
51.00%
3-Year Net Income Growth per Share
50.61%
10-Year Shareholders Equity Growth per Share
93.78%
5-Year Shareholders Equity Growth per Share
18.07%
3-Year Shareholders Equity Growth per Share
-0.44%
10-Year Dividend per Share Growth per Share
560.63%
5-Year Dividend per Share Growth per Share
494.47%
3-Year Dividend per Share Growth per Share
393.56%
Receivables Growth
-35.49%
Inventory Growth
6.26%
Asset Growth
-1.84%
Book Value per Share Growth
-1.80%
Debt Growth
1689.12%
R&D Expense Growth
12.24%
SGA Expenses Growth
18.58%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 12,044,922,591.6, captures the company's total value, considering both debt and equity.
Income quality, 1.52, assesses the reliability of reported earnings.
The sales, general, and administrative to revenue ratio, 0.01, gauges operational efficiency, while the research and development to revenue, 2.59%, highlights investment in innovation.
The ratio of intangibles to total assets, 7.23%, indicates the value of non-physical assets, and capex to operating cash flow, -19.38%, measures reinvestment capability.
cards.indicator
cards.value
Enterprise Value
12,044,922,591.6
Income Quality
1.52
Sales General and Administrative to Revenue
0.01
Research and Development to Revenue
2.59%
Intangibles to Total Assets
7.23%
Capex to Operating Cash Flow
-19.38%
Capex to Revenue
-4.83%
Capex to Depreciation
-170.80%
Stock-Based Compensation to Revenue
0.21%
Graham Number
12.49
Return on Tangible Assets
12.46%
Graham Net Net
0.65
Working Capital
811,177,373
Tangible Asset Value
4,081,198,832
Net Current Asset Value
792,630,458
Average Receivables
717,653,390.5
Average Payables
177,316,841
Average Inventory
394,195,874
Days Sales Outstanding
47
Days Payables Outstanding
27
Days of Inventory On Hand
94
ROIC
18.09%
ROE
0.18%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 4.13, and the price to book ratio, 4.13, reflect the market's valuation relative to the company's book value.
The price to sales ratio, 3.98, provides a perspective on valuation in relation to sales.
Ratios like price to free cash flows, 19.20, and price to operating cash flows, 15.46, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
4.13
Price to Book Ratio
4.13
Price to Sales Ratio
3.98
Price Cash Flow Ratio
15.46
Price Earnings to Growth Ratio
1.63
Enterprise Value Multiple
19.04
Price Fair Value
4.13
Price to Operating Cash Flow Ratio
15.46
Price to Free Cash Flows Ratio
19.20
Price to Tangible Book Ratio
3.48
Enterprise Value to Sales
2.78
Enterprise Value Over EBITDA
12.75
EV to Operating Cash Flow
11.18
Earnings Yield
5.32%
Free Cash Flow Yield
6.52%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
